
Insiders Updates
Vanda Pharmaceuticals Inc (VNDA) Becoming More Attractive for Investors
Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 on
Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 on
Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 on
Vanda Pharmaceuticals Inc’s recent filing unveils that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vanda Pharmaceuticals
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) does about 670.95K shares in volume on a normal day but saw 493956 shares change hands